Bifidobacterium breve UCC2003 Exopolysaccharide Modulates the Early Life Microbiota by Acting as a Potential Dietary Substrate.
Deborah PüngelAgatha TreveilMatthew J DalbyShabhonam CaimIan J ColquhounCatherine BoothJennifer KetskemetyTamas KorcsmarosDouwe van SinderenMelissa A E LawsonLindsay J HallPublished in: Nutrients (2020)
These data indicate that B. breve UCC2003 EPS is potentially metabolized by infant microbiota members, leading to differential microbial metabolism and altered metabolite by-products. Overall, these findings may allow development of EPS-specific strategies to promote infant health.